REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugsREGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugs

For research purposes only. Full disclaimer →

Research Library

749 papers · 104 analysis articles

Research Analysis

Curated deep-dives into the latest peptide research

Exploring BPC-157 Safety and Pharmacokinetics: A Phase I Trial

Read analysis

BPC-157 Study Shows Promise in Accelerating Recovery from Hamstring Injuries

Read analysis

FDA Paves Way for New Testosterone Therapy Research in Men

Read analysis

Semaglutide Injection Remains on Market; FDA Clears Path for Continued Use

Read analysis

FDA Extends Pharmacy Compounding Advisory Committee’s Charter for Peptide Research and Patient Safety

Read analysis

FDA Proposes to Restrict Use of Semaglutide and Other Peptide Drugs in Compound Form

Read analysis

Papers Database

AllReviewSystematic ReviewMeta-AnalysisRCTClinical TrialHuman TrialPreclinicalCase ReportPreprint
PubMedbioRxivSemantic Scholar

Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes : A Systematic Review of Randomized Controlled Trials.

Moiz Areesha et al.Annals of internal medicine2025
pubmedSystematic Review

Echinocandins Pharmacokinetics: A Comprehensive Review of Micafungin, Caspofungin, Anidulafungin, and Rezafungin Population Pharmacokinetic Models and Dose Optimization in Special Populations.

Albanell-Fernández MartaClinical pharmacokinetics2025
pubmedSystematic ReviewHumanHigh Qualitymicafungincaspofungin

Efficacy and safety of retatrutide for the treatment of obesity: a systematic review of clinical trials.

Misra Saurav et al.Journal of basic and clinical physiology and pharmacology2025
pubmedSystematic ReviewHumanHigh Qualityretatrutideglucagon receptor agonist

A systematic review of the effect of semaglutide on lean mass: insights from clinical trials.

Bikou Alexia et al.Expert opinion on pharmacotherapy2024
pubmedSystematic Review

Comprehensive Review of the Safety and Efficacy of Thymosin Alpha 1 in Human Clinical Trials.

Dinetz Elliot et al.Alternative therapies in health and medicine2024
pubmedSystematic ReviewHumanHigh QualityThymosin Alpha 1Tα1

Effects of GLP-1 receptor agonists on neurological complications of diabetes.

García-Casares Natalia et al.Reviews in endocrine & metabolic disorders2023
pubmedSystematic Review

Adverse drug reactions of GLP-1 agonists: A systematic review of case reports.

Shetty Rashmi et al.Diabetes & metabolic syndrome2022
pubmedSystematic Review

Tirzepatide: A Systematic Update.

Forzano Imma et al.International journal of molecular sciences2022
pubmedSystematic ReviewHumanHigh QualityTirzepatideGIP

Peptide Regulation of Gene Expression: A Systematic Review.

Khavinson Vladimir Khatskelevich et al.Molecules (Basel, Switzerland)2021
pubmedSystematic ReviewHumanHigh Qualitygene expression regulationDNA methylation

NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis.

Braidy Nady et al.Experimental gerontology2020
pubmedSystematic Review

Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder.

Mayer Danielle et al.The Annals of pharmacotherapy2020
pubmedSystematic Review